Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern. 2021

Lisa H Tostanoski, and Jingyou Yu, and Noe B Mercado, and Katherine McMahan, and Catherine Jacob-Dolan, and Amanda J Martinot, and Cesar Piedra-Mora, and Tochi Anioke, and Aiquan Chang, and Victoria M Giffin, and David L Hope, and Huahua Wan, and Esther A Bondzie, and Shant H Mahrokhian, and Linda M Wrijil, and Katherine Bauer, and Laurent Pessaint, and Maciel Porto, and Joseph Piegols, and Andrew Faudree, and Brittany Spence, and Swagata Kar, and Fatima Amanat, and Florian Krammer, and Hanne Andersen, and Mark G Lewis, and Frank Wegmann, and Roland Zahn, and Hanneke Schuitemaker, and Dan H Barouch
Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern have emerged and may pose a threat to both the efficacy of vaccines based on the original WA1/2020 strain and the natural immunity induced by infection with earlier SARS-CoV-2 variants. We investigated how mutations in the spike protein of circulating SARS-CoV-2 variants, which have been shown to partially evade neutralizing antibodies, affect natural and vaccine-induced immunity. We adapted a Syrian hamster model of moderate to severe clinical disease for two variant strains of SARS-CoV-2: B.1.1.7 (alpha variant) and B.1.351 (beta variant). We then assessed the protective efficacy conferred by either natural immunity from WA1/2020 infection or by vaccination with a single dose of the adenovirus serotype 26 vaccine, Ad26.COV2.S. Primary infection with the WA1/2020 strain provided potent protection against weight loss and viral replication in lungs after rechallenge with WA1/2020, B.1.1.7, or B.1.351. Ad26.COV2.S induced cross-reactive binding and neutralizing antibodies that were reduced against the B.1.351 strain compared with WA1/2020 but nevertheless still provided robust protection against B.1.351 challenge, as measured by weight loss and pathology scoring in the lungs. Together, these data support hamsters as a preclinical model to study protection against emerging variants of SARS-CoV-2 conferred by prior infection or vaccination.

UI MeSH Term Description Entries
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000086663 COVID-19 Vaccines Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19. 2019 Novel Coronavirus Vaccine,2019 Novel Coronavirus Vaccines,2019-nCoV Vaccine,2019-nCoV Vaccines,COVID 19 Vaccine,COVID-19 Vaccine,COVID-19 Virus Vaccine,COVID-19 Virus Vaccines,COVID19 Vaccine,COVID19 Vaccines,COVID19 Virus Vaccine,COVID19 Virus Vaccines,Coronavirus Disease 2019 Vaccine,Coronavirus Disease 2019 Vaccines,Coronavirus Disease 2019 Virus Vaccine,Coronavirus Disease 2019 Virus Vaccines,Coronavirus Disease-19 Vaccine,Coronavirus Disease-19 Vaccines,SARS Coronavirus 2 Vaccines,SARS-CoV-2 Vaccine,SARS-CoV-2 Vaccines,SARS2 Vaccine,SARS2 Vaccines,2019 nCoV Vaccine,2019 nCoV Vaccines,COVID 19 Vaccines,COVID 19 Virus Vaccine,COVID 19 Virus Vaccines,Coronavirus Disease 19 Vaccine,Coronavirus Disease 19 Vaccines,SARS CoV 2 Vaccine,SARS CoV 2 Vaccines,Vaccine, 2019-nCoV,Vaccine, COVID 19,Vaccine, COVID-19,Vaccine, COVID-19 Virus,Vaccine, COVID19,Vaccine, COVID19 Virus,Vaccine, Coronavirus Disease-19,Vaccine, SARS-CoV-2,Vaccine, SARS2,Vaccines, 2019-nCoV,Vaccines, COVID-19,Vaccines, COVID-19 Virus,Vaccines, COVID19,Vaccines, COVID19 Virus,Vaccines, Coronavirus Disease-19,Vaccines, SARS-CoV-2,Vaccines, SARS2,Virus Vaccine, COVID-19,Virus Vaccine, COVID19,Virus Vaccines, COVID-19,Virus Vaccines, COVID19
D000090984 Ad26COVS1 A viral vector vaccine designed against SARS-CoV-2 developed by Johnson & Johnson. Its vector encodes the SARS-CoV-2 Spike protein. COVID-19 Vaccine Johnson & Johnson,Johnson & Johnson Covid-19 Vaccine,Ad26.COV2.S,JNJ 78436735,JNJ-78436735,COVID 19 Vaccine Johnson & Johnson,JNJ78436735,Johnson & Johnson Covid 19 Vaccine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

Lisa H Tostanoski, and Jingyou Yu, and Noe B Mercado, and Katherine McMahan, and Catherine Jacob-Dolan, and Amanda J Martinot, and Cesar Piedra-Mora, and Tochi Anioke, and Aiquan Chang, and Victoria M Giffin, and David L Hope, and Huahua Wan, and Esther A Bondzie, and Shant H Mahrokhian, and Linda M Wrijil, and Katherine Bauer, and Laurent Pessaint, and Maciel Porto, and Joseph Piegols, and Andrew Faudree, and Brittany Spence, and Swagata Kar, and Fatima Amanat, and Florian Krammer, and Hanne Andersen, and Mark G Lewis, and Frank Wegmann, and Roland Zahn, and Hanneke Schuitemaker, and Dan H Barouch
January 2022, Frontiers in immunology,
Lisa H Tostanoski, and Jingyou Yu, and Noe B Mercado, and Katherine McMahan, and Catherine Jacob-Dolan, and Amanda J Martinot, and Cesar Piedra-Mora, and Tochi Anioke, and Aiquan Chang, and Victoria M Giffin, and David L Hope, and Huahua Wan, and Esther A Bondzie, and Shant H Mahrokhian, and Linda M Wrijil, and Katherine Bauer, and Laurent Pessaint, and Maciel Porto, and Joseph Piegols, and Andrew Faudree, and Brittany Spence, and Swagata Kar, and Fatima Amanat, and Florian Krammer, and Hanne Andersen, and Mark G Lewis, and Frank Wegmann, and Roland Zahn, and Hanneke Schuitemaker, and Dan H Barouch
March 2021, NPJ vaccines,
Lisa H Tostanoski, and Jingyou Yu, and Noe B Mercado, and Katherine McMahan, and Catherine Jacob-Dolan, and Amanda J Martinot, and Cesar Piedra-Mora, and Tochi Anioke, and Aiquan Chang, and Victoria M Giffin, and David L Hope, and Huahua Wan, and Esther A Bondzie, and Shant H Mahrokhian, and Linda M Wrijil, and Katherine Bauer, and Laurent Pessaint, and Maciel Porto, and Joseph Piegols, and Andrew Faudree, and Brittany Spence, and Swagata Kar, and Fatima Amanat, and Florian Krammer, and Hanne Andersen, and Mark G Lewis, and Frank Wegmann, and Roland Zahn, and Hanneke Schuitemaker, and Dan H Barouch
May 2022, Vaccines,
Lisa H Tostanoski, and Jingyou Yu, and Noe B Mercado, and Katherine McMahan, and Catherine Jacob-Dolan, and Amanda J Martinot, and Cesar Piedra-Mora, and Tochi Anioke, and Aiquan Chang, and Victoria M Giffin, and David L Hope, and Huahua Wan, and Esther A Bondzie, and Shant H Mahrokhian, and Linda M Wrijil, and Katherine Bauer, and Laurent Pessaint, and Maciel Porto, and Joseph Piegols, and Andrew Faudree, and Brittany Spence, and Swagata Kar, and Fatima Amanat, and Florian Krammer, and Hanne Andersen, and Mark G Lewis, and Frank Wegmann, and Roland Zahn, and Hanneke Schuitemaker, and Dan H Barouch
May 2022, Vaccines,
Lisa H Tostanoski, and Jingyou Yu, and Noe B Mercado, and Katherine McMahan, and Catherine Jacob-Dolan, and Amanda J Martinot, and Cesar Piedra-Mora, and Tochi Anioke, and Aiquan Chang, and Victoria M Giffin, and David L Hope, and Huahua Wan, and Esther A Bondzie, and Shant H Mahrokhian, and Linda M Wrijil, and Katherine Bauer, and Laurent Pessaint, and Maciel Porto, and Joseph Piegols, and Andrew Faudree, and Brittany Spence, and Swagata Kar, and Fatima Amanat, and Florian Krammer, and Hanne Andersen, and Mark G Lewis, and Frank Wegmann, and Roland Zahn, and Hanneke Schuitemaker, and Dan H Barouch
March 2022, Cell reports. Medicine,
Lisa H Tostanoski, and Jingyou Yu, and Noe B Mercado, and Katherine McMahan, and Catherine Jacob-Dolan, and Amanda J Martinot, and Cesar Piedra-Mora, and Tochi Anioke, and Aiquan Chang, and Victoria M Giffin, and David L Hope, and Huahua Wan, and Esther A Bondzie, and Shant H Mahrokhian, and Linda M Wrijil, and Katherine Bauer, and Laurent Pessaint, and Maciel Porto, and Joseph Piegols, and Andrew Faudree, and Brittany Spence, and Swagata Kar, and Fatima Amanat, and Florian Krammer, and Hanne Andersen, and Mark G Lewis, and Frank Wegmann, and Roland Zahn, and Hanneke Schuitemaker, and Dan H Barouch
March 2023, NPJ vaccines,
Lisa H Tostanoski, and Jingyou Yu, and Noe B Mercado, and Katherine McMahan, and Catherine Jacob-Dolan, and Amanda J Martinot, and Cesar Piedra-Mora, and Tochi Anioke, and Aiquan Chang, and Victoria M Giffin, and David L Hope, and Huahua Wan, and Esther A Bondzie, and Shant H Mahrokhian, and Linda M Wrijil, and Katherine Bauer, and Laurent Pessaint, and Maciel Porto, and Joseph Piegols, and Andrew Faudree, and Brittany Spence, and Swagata Kar, and Fatima Amanat, and Florian Krammer, and Hanne Andersen, and Mark G Lewis, and Frank Wegmann, and Roland Zahn, and Hanneke Schuitemaker, and Dan H Barouch
April 2023, Nature communications,
Lisa H Tostanoski, and Jingyou Yu, and Noe B Mercado, and Katherine McMahan, and Catherine Jacob-Dolan, and Amanda J Martinot, and Cesar Piedra-Mora, and Tochi Anioke, and Aiquan Chang, and Victoria M Giffin, and David L Hope, and Huahua Wan, and Esther A Bondzie, and Shant H Mahrokhian, and Linda M Wrijil, and Katherine Bauer, and Laurent Pessaint, and Maciel Porto, and Joseph Piegols, and Andrew Faudree, and Brittany Spence, and Swagata Kar, and Fatima Amanat, and Florian Krammer, and Hanne Andersen, and Mark G Lewis, and Frank Wegmann, and Roland Zahn, and Hanneke Schuitemaker, and Dan H Barouch
February 2022, Nature communications,
Lisa H Tostanoski, and Jingyou Yu, and Noe B Mercado, and Katherine McMahan, and Catherine Jacob-Dolan, and Amanda J Martinot, and Cesar Piedra-Mora, and Tochi Anioke, and Aiquan Chang, and Victoria M Giffin, and David L Hope, and Huahua Wan, and Esther A Bondzie, and Shant H Mahrokhian, and Linda M Wrijil, and Katherine Bauer, and Laurent Pessaint, and Maciel Porto, and Joseph Piegols, and Andrew Faudree, and Brittany Spence, and Swagata Kar, and Fatima Amanat, and Florian Krammer, and Hanne Andersen, and Mark G Lewis, and Frank Wegmann, and Roland Zahn, and Hanneke Schuitemaker, and Dan H Barouch
January 2022, Science (New York, N.Y.),
Lisa H Tostanoski, and Jingyou Yu, and Noe B Mercado, and Katherine McMahan, and Catherine Jacob-Dolan, and Amanda J Martinot, and Cesar Piedra-Mora, and Tochi Anioke, and Aiquan Chang, and Victoria M Giffin, and David L Hope, and Huahua Wan, and Esther A Bondzie, and Shant H Mahrokhian, and Linda M Wrijil, and Katherine Bauer, and Laurent Pessaint, and Maciel Porto, and Joseph Piegols, and Andrew Faudree, and Brittany Spence, and Swagata Kar, and Fatima Amanat, and Florian Krammer, and Hanne Andersen, and Mark G Lewis, and Frank Wegmann, and Roland Zahn, and Hanneke Schuitemaker, and Dan H Barouch
May 2021, medRxiv : the preprint server for health sciences,
Copied contents to your clipboard!